• SENSEX 73,377.24
    -229.51 (--0.31%)
  • BANKNIFTY 54,366.70
    79.35 (+0.15%)
  • TVS Holdings
    11,337.15 16,150.00(%)
  • NSE
    1,774.00 1,878.00(%)
  • Ather Energy
    1,702.00 1,741.90(%)
  • Apollo Micro Sys
    446.80 466.70(%)
  • LIC Housing Fin.
    512.00 598.00(%)
  • DLF
    672.55 786.40(%)
  • Persistent Systems
    5,695.50 4,242.65(%)
  • Sona BLW Precis.
    863.90 843.90(%)
  • Adani Enterp.
    2,431.85 1,753.45(%)
  • Federal Bank
    348.20 364.95(%)
  • Reliance Industries
    1,184.00 1,152.30(%)
  • Sky Gold & Diam.
    965.00 1,083.00(%)
  • OneSource Speci.
    1,606.35 1,924.00(%)
  • HDFC Bank
    680.10 682.00(%)
  • Tonbo Imaging
    1,300.00 1,331.45(%)
  • SBI Life Insuran
    1,626.75 1,609.20(%)
  • Torrent Pharma.
    4,649.20 5,249.95(%)
  • Max Healthcare
    857.00 1,196.50(%)
  • GE Vernova T&D
    4,025.00 5,650.00(%)
  • Acutaas Chemical
    3,798.00 3,735.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

BDH Industries Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4720.0
  • ISIN : INE278D01018
411.30 -12 (-2.92%)
  • As on 27 Oct 2026 (EOD)

  • Today’s Low

    411.00

  • Today’s High

    436.90

  • Open

    423.65

  • Perv Close

    423.65

  • 52W Low

    340.15

  • 52W High

    610.00

Key Indicators

  • P/E(TTM)

    20.23

  • Mar.Cap (₹Cr.)

    236.91

  • Div & Yield %

    1.22

  • Book Value(₹)

    131.42

  • Debt-Equity Ratio

    -2.92

  • AGM Date

    26-Oct-2026

  • EPS

    20.33

  • P/E Ratio

    20.23

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    236.91

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.76

  • BV (₹)

    131.40

  • Sales( ₹ in Cr.)

    95.95

  • NP (in Cr.)

    10.81

  • NP Var(%)

    17.0

  • Div%

    50.0

  • CPS (₹)

    20.30

  • EPS (₹)

    18.80

  • Traded Value (₹ in Lakhs)

    236.91

  • 52 Week High

    610.00

  • 52 Week Low

    340.15

  • Price BSE

    411.0

  • Price NSE

    1.00

  • Market Capital( in Cr.)

    236.91

  • P/C Ratio

    20.30

  • P/E Ratio

    21.90

  • Price Vs.BV

    18.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 95.95 66.51 85.83 74.46 69.39 57.45
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 95.95 66.51 85.83 74.46 69.39 57.45
Other Income 2.24 1.84 1.58 0.84 1.33 1.30
Stock Adjustments 0.61 1.00 -0.61 -1.89 0.55 1.17
Total Income 98.80 69.35 86.80 73.41 71.27 59.92
EXPENDITURE :            
Raw Materials 70.53 42.39 59.66 47.80 49.53 38.35
Power and Fuel Cost 1.35 1.76 1.78 1.74 1.41 1.49
Employee Cost 7.55 7.44 7.43 6.96 6.62 6.26
Other Manufacturing Expenses 0.53 0.63 0.62 0.86 0.43 0.97
Selling and Administration Expenses 2.48 3.45 3.10 4.09 2.67 2.84
Miscellaneous Expenses 0.25 0.22 0.19 0.18 0.21 0.20
Employee Benefit Expenses 7.55 7.44 7.43 6.96 6.62 6.26
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 82.69 55.89 72.79 61.62 60.87 50.11
Operating Profit 16.12 13.44 14.01 11.80 10.42 9.81
Interest 0.06 0.07 0.18 0.16 0.23 0.28
Gross Profit 16.06 13.37 13.83 11.64 10.19 9.53
Depreciation 0.87 0.91 0.57 0.57 0.63 0.79
Profit Before Tax 15.19 12.46 13.26 11.07 9.56 8.74
Current Tax 3.54 2.54 2.94 2.87 2.33 2.45
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.84 0.65 0.44 -0.01 0.00 -0.06
Reported Net Profit 10.81 9.27 9.87 8.20 7.22 6.36
Extraordinary Items 0.00 0.00 0.00 0.00 0.34 0.00
Adjusted Net Profit 10.81 9.27 9.87 8.20 6.88 6.36
Adjustment below Net Profit 0.03 -0.08 -0.10 -0.01 0.04 -0.08
P & L Balance brought forward 45.76 40.55 34.54 29.65 25.20 21.31
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.21 3.98 3.76 3.30 2.81 2.39
P & L Balance carried down 52.39 45.76 40.55 34.54 29.65 25.20
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 45.00 45.00 40.00 36.00 30.00
Dividend Per Share(Rs) 5.00 4.50 4.50 4.00 3.60 3.00
Earnings Per Share-Unit Curr 18.78 16.11 17.14 14.25 12.55 10.71
Earnings Per Share(Adj)-Unit Curr 18.78 16.11 17.14 14.25 12.55 10.71
Book Value 131.47 117.14 105.67 92.71 82.07 70.24
Book Value(Adj)-Unit Curr 131.47 117.14 105.67 92.71 82.07 70.24

Shareholding Pattern

  • Promoter Group

    49.70%

  • Public Share Holding

    50.30%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 464,380 464,380.00 464,380 464,380
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 464,380 8.07 464,380 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,396,760 41.63 2,396,760 17
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,396,760 41.63 2,396,760 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 16,024 0.28 16,024 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 16,024 0.28 16,024 1
2] Non Institution
Bodies Corporate 7,390 0.13 7,290 22
Clearing Members 202,046 3.51 202,046 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 72,522 1.26 72,522 75
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 315,543 5.48 315,543 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 271,353 4.71 271,353 10
Individuals holding nominal share capital up to Rs. 1 lakh 1,433,688 24.90 1,360,388 4,304
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 577,594 10.03 577,594 93
Sub Total 2,880,136 50.03 2,806,736 4,506
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,757,300 100.00 5,683,900 4,525

Company Background

BDH Industries LtdPharmaceuticals - Indian - Formulations

  • BDH Industries Ltd
  • BSE Code : 4720.0
  • ISIN : INE278D01018

  • Incorporation Year

    1990

  • Registered Office

    Nair Baug
    Akurli Road Kandivli (E), Mumbai,
    Maharashtra-400101

  • Telephone

    91-22-28871370/28870834

  • FAX

    91-22-28868349

  • Chairman

    Jayashree Nair

  • Managing Director

    Jayashree Nair

  • Company Secretary

    Nikita Phatak

  • Auditor

    CLB & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    TSR Consultants P Ltd
    C-101 1st Floor,
    247 Park Vikhroli W,Lal Bahadur Marg
    Mumbai - Mumbai - 400 083

BDH Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
BDH Industries 411.30 98.20 95.95 20.23 20.82
Abbott India 25,222.05 7,217.19 6,929.05 33.19 43.78
Astrazeneca Phar 6,074.75 2,304.07 2,275.58 89.53 27.86
Glaxosmi. Pharma 2,448.15 3,932.76 3,790.20 39.11 58.17
Novartis India 1,788.65 393.10 354.33 45.17 15.94
Cipla 1,353.00 20,102.60 18,979.95 35.56 13.88
Bliss GVS Pharma 617.15 773.53 729.81 57.36 12.51
Amrutanjan Healt 490.00 520.13 502.55 26.25 24.16
Fermenta Biotec. 445.65 474.15 450.25 20.81 18.77
Guj. Themis Bio. 337.75 168.25 165.82 90.31 18.05
Ambalal Sarabhai 35.99 19.52 3.94 66.65 6.77